All News

The Centers for Disease Control and Prevention and 25 national health organizations have issued a joint statement on antibiotic resistance they say is designed to "both conserve and replenish our antibiotic resources."

Merck has confirmed that the FDA Nonprescription Drug Advisory Committee proposed that the FDA consider labeling modifications as part of its review of oxybutynin transdermal system (Oxytrol) as an over-the-counter treatment for overactive bladder in women.

More than two-thirds of U.S. primary care physicians now use electronic health records (EHRs), but less than one-fifth report that they routinely receive timely information from specialists or hospitals, according to a survey of physicians in the U.S. and nine other countries.

The FDA recently granted clearance to separate devices for bladder scanning and placement of suprapubic catheters.

An experimental form of brachytherapy was highly efficacious and minimally toxic to healthy tissue in a mouse model of cancer, according to a recent study.

Recent research suggests that two components of red meat?dietary protein and dietary iron?may combine to form powerful carcinogens that increase risk for bladder cancer.

Low depressive symptoms and a longer telomere length are compelling factors that contribute to a prolonged life for bladder cancer patients, say researchers at The University of Texas MD Anderson Cancer Center, Houston.

Women without pregnancy complications or maternal risk factors for complications have low rates of significant pelvic floor dysfunction after giving birth, whether they deliver vaginally or via cesarean section, recent research shows.

An implantable tibial nerve stimulation device appears to be safe and durable in patients with overactive bladder, results of a long-term pilot study showed.

Mishaps around the home that lead to emergency room visits for genital injuries are common and may be preventable, according to a comprehensive survey of genital injuries over the last decade conducted by urologists at the University of California, San Francisco.

A recently published study supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.

Stereotactic body radiotherapy appears to be an effective treatment option for patients with organ-confined prostate cancer, according to two separate studies presented at the American Association for Radiation Oncology annual meeting in Boston.

An online poll of New England Journal of Medicine readers shows a lack of consensus over prostate cancer screening, with a little over half of respondents recommending screening for a 55-year-old man.

Urologists who treat Medicare patients face a 1% pay cut under a Centers for Medicare & Medicaid Services final rule with comment period issued Nov. 1.

Less than 5% of websites describing prostate cancer are written below a high school reading level, even though 90 million American adults read below this level, a new study found.

A new online medical database designed to help men diagnosed with low-grade prostate cancer track the progression of their disease while avoiding complications from overtreatment recently launched.

Stereotactic radiosurgery shows promise as a therapeutic option for patients with localized primary renal cancer who are considered poor surgical candidates and who do not have a prior history of pelvic or abdominal radiation, according to research presented at the American Society for Radiation Oncology annual meeting in Boston.

Annual PSA screening yields a greater quality-adjusted life expectancy among patients who have a high risk of developing metastatic disease in comparison to unscreened patients, according to a recent study.

A recent report from the Government Accountability Office (GAO) is highly critical of physician self-referral for advanced imaging services, indicating that it significantly raises Medicare costs.

The November election is over, but the real campaign has just begun. For urologists, that means urgent action on efforts to reverse the payment cuts mandated by the sustainable growth rate formula and the fiscal cliff, to name two immediate priorities.

Empiric use of antibiotics for a newly elevated PSA measurement in asymptomatic men appears to have no clinical benefit, according to results of a recent multicenter study.

Researchers at Northwestern University in Chicago are exploring the complex web woven by cytokines in uropathogenic Escherichia coli bladder infections and in so doing, are opening avenues for potential therapies for these infections.

Obesity may have a significant effect on prostate growth, a new analysis of the original data collected in a prospective, randomized, placebo-controlled clinical trial indicates.

A recent report from the Center for Public Integrity found that during a 10-year period, physicians increasingly billed Medicare for higher paying codes than in the past.

Patients younger than 50 years of age at the time of radical prostatectomy appear to have more favorable disease characteristics, data from a European consecutive cohort of non-screened men with clinically localized disease show.

A more thoughtful approach to antimicrobial prophylaxis is to obtain rectal swab cultures ahead of time and determine which bacteria are susceptible to antibiotics.

In this article, James M. Dupree, MD, MPH; Maddie Jones; and Christopher M. Gonzalez, MD, MBA explain what constitutes an accountable care organization and how a urologist might (or might not) interact with one.

Bicalutamide monotherapy in men with locally advanced or metastatic prostate cancer is as initially effective as LHRH analogs but can be far more beneficial in preserving bone mineral density, muscle tone, sexual function, and quality of life, say British researchers.